Anne Bodilsen1, Karsten Bjerre2, Birgitte V Offersen3, Pernille Vahl4, Nikolaj Amby3, J Michael Dixon5, Bent Ejlertsen2,6, Jens Overgaard7, Peer Christiansen8. 1. Department of Breast and Endocrine Surgery, Aarhus University Hospital, Aarhus, Denmark. 2. Danish Breast Cancer Cooperative Group, Copenhagen, Denmark. 3. Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. 4. Department of Pathology, Aarhus University Hospital, Aarhus, Denmark. 5. Breakthrough Research Unit Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom. 6. Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. 7. Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark. 8. Department of Surgery P, Breast Surgery Unit, Aarhus University Hospital/Randers Regional Hospital, Aarhus, Denmark.
Abstract
BACKGROUND AND METHOD: The association between margin width and ipsilateral breast tumour recurrence (IBTR, defined as invasive recurrence) was investigated in a population-based nationwide cohort of 11,900 patients undergoing breast-conserving therapy for invasive cancer. RESULTS: The median follow-up was 4.9 years. The cumulative incidence of IBTR at 5 and 9 years was 2.4% and 5.9%, respectively. A final positive margin increased the risk of IBTR (HR 2.51; 95% CI 1.02-6.23). No decrease in IBTR with a wider negative margin compared to a narrow but negative margin was observed in the adjusted analysis of margin width (>0 to <2 mm vs. ≥2 to <5 mm vs. ≥5 mm (reference): HR 1.54 (CI 95% 0.81-2.93) vs. 0.95 (CI 95% 0.56-1.62) vs. 1). However, few patients had narrow margins. The factors associated with increased IBTR were young age (P < 0.001), >4 positive lymph nodes (P = 0.008) and re-excision (P = 0.003). A reduced risk of IBTR was observed with chemotherapy (P < 0.001), boost radiation (P = 0.023) and ER positivity (P < 0.001). CONCLUSION: An overall low rate of IBTR was observed. A final positive margin was associated with a more than twofold risk of IBTR. There was no evidence for better local control with wider margins, but the data were insufficient to show whether narrow margins were as good as wider negative margins in terms of local control. J. Surg. Oncol. 2016;113:609-615.
BACKGROUND AND METHOD: The association between margin width and ipsilateral breast tumour recurrence (IBTR, defined as invasive recurrence) was investigated in a population-based nationwide cohort of 11,900 patients undergoing breast-conserving therapy for invasive cancer. RESULTS: The median follow-up was 4.9 years. The cumulative incidence of IBTR at 5 and 9 years was 2.4% and 5.9%, respectively. A final positive margin increased the risk of IBTR (HR 2.51; 95% CI 1.02-6.23). No decrease in IBTR with a wider negative margin compared to a narrow but negative margin was observed in the adjusted analysis of margin width (>0 to <2 mm vs. ≥2 to <5 mm vs. ≥5 mm (reference): HR 1.54 (CI 95% 0.81-2.93) vs. 0.95 (CI 95% 0.56-1.62) vs. 1). However, few patients had narrow margins. The factors associated with increased IBTR were young age (P < 0.001), >4 positive lymph nodes (P = 0.008) and re-excision (P = 0.003). A reduced risk of IBTR was observed with chemotherapy (P < 0.001), boost radiation (P = 0.023) and ER positivity (P < 0.001). CONCLUSION: An overall low rate of IBTR was observed. A final positive margin was associated with a more than twofold risk of IBTR. There was no evidence for better local control with wider margins, but the data were insufficient to show whether narrow margins were as good as wider negative margins in terms of local control. J. Surg. Oncol. 2016;113:609-615.
Authors: Jennifer Yu; Leisha C Elmore; Amy E Cyr; Rebecca L Aft; William E Gillanders; Julie A Margenthaler Journal: J Am Coll Surg Date: 2017-04-14 Impact factor: 6.113
Authors: Lisanne L de Boer; Torre M Bydlon; Frederieke van Duijnhoven; Marie-Jeanne T F D Vranken Peeters; Claudette E Loo; Gonneke A O Winter-Warnars; Joyce Sanders; Henricus J C M Sterenborg; Benno H W Hendriks; Theo J M Ruers Journal: J Transl Med Date: 2018-12-19 Impact factor: 5.531
Authors: James R Bundred; Sarah Michael; Beth Stuart; Ramsey I Cutress; Kerri Beckmann; Bernd Holleczek; Jane E Dahlstrom; Jacqui Gath; David Dodwell; Nigel J Bundred Journal: BMJ Date: 2022-09-21
Authors: E Heeg; M B Jensen; L R Hölmich; A Bodilsen; R A E M Tollenaar; A V Laenkholm; B V Offersen; B Ejlertsen; M A M Mureau; P M Christiansen Journal: Br J Surg Date: 2020-08-06 Impact factor: 6.939